Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder

Clinical trial NCT00374543 · TERMINATED

Trial details

NCT number: NCT00374543
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Generalized Anxiety Disorder Bipolar Disorder

Start date: 2006-02-01
Primary completion: 2007-10-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.